FDA Takes Unapproved Quinine Drugs Off The Market
This article was originally published in The Pink Sheet Daily
Physicians warned against prescribing for leg cramps, which accounts for 70% of usage.
You may also be interested in...
Company hopes to get FDA to remove other quinine products from the market.
FDA is focusing initially on drugs containing the antihistamine carbinoxamine because of safety concerns in children.
Industry also seems supportive of the idea, while Pew touts the power of the power of track-and-trace as a deterrent.